Glioma targeting peptide modified apoferritin nanocage

Glioma targeting peptide modified apoferritin nanocage

Therapeutic outcome for the treatment of glioma was often limited due to the non-targeted nature of drugs and the physiological barriers, including the blood-brain barrier (BBB) and the blood-brain tumor barrier (BBTB). An ideal glioma-targeted delivery system must be sufficiently potent to cross th...

Full description

Bibliographic Details
Main Authors: Meifang Zhai, Yuli Wang, Ligang Zhang, Meng Liang, Shiyao Fu, Lin Cui, Meiyan Yang, Wei Gong, Zhiping Li, Lian Yu, Xiangyang Xie, Chunrong Yang, Yang Yang, Chunsheng Gao
Format: Article
Language:English
Published: Taylor & Francis Group 2018-01-01
Series:Drug Delivery
Subjects:
apoferritin nanocage
gkrk peptide
glioma
systemic targeted drug delivery
chemotherapy
Online Access:http://dx.doi.org/10.1080/10717544.2018.1464082

Internet

http://dx.doi.org/10.1080/10717544.2018.1464082

Similar Items